These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 19635753)
1. Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. Benton G; Crooke E; George J FASEB J; 2009 Nov; 23(11):3884-95. PubMed ID: 19635753 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Cheng JC; Auersperg N; Leung PC Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913 [TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364 [TBL] [Abstract][Full Text] [Related]
4. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928 [TBL] [Abstract][Full Text] [Related]
5. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Xie Q; Bai Q; Zou LY; Zhang QY; Zhou Y; Chang H; Yi L; Zhu JD; Mi MT Genes Chromosomes Cancer; 2014 May; 53(5):422-31. PubMed ID: 24532317 [TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
7. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b. Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [TBL] [Abstract][Full Text] [Related]
9. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors. Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556 [TBL] [Abstract][Full Text] [Related]
11. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452 [TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibitor assay system based on the HBx-induced DNA methylation of E-cadherin. Lee H; Sohn JB; Kim SS; Jang KL Biochem Biophys Res Commun; 2013 Aug; 438(3):540-5. PubMed ID: 23906757 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649 [TBL] [Abstract][Full Text] [Related]
14. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells. Pakneshan P; Szyf M; Rabbani SA Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232 [TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines. Sowińska A; Jagodzinski PP Cancer Lett; 2007 Sep; 255(1):153-9. PubMed ID: 17532557 [TBL] [Abstract][Full Text] [Related]
16. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines. Saikawa Y; Kubota T; Maeda S; Otani Y; Kumai K; Kitajima M Oncol Rep; 2004 Sep; 12(3):527-31. PubMed ID: 15289832 [TBL] [Abstract][Full Text] [Related]
18. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
20. Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells. Huang Y; Song H; Hu H; Cui L; You C; Huang L Mol Med Rep; 2012 Oct; 6(4):872-8. PubMed ID: 22825485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]